2024 Conference Coverage


 

MS Relapse Redefined: Distinguishing True Relapses from Pseudoexacerbations in the ULTIMATE I and II Trials Comparing Ublituximab vs Teriflunomide

174 views
April 25, 2024
1 Comment
Login to view comments. Click here to Login